View |
|
DR-XY25047
|
Cisplatin
|
Cytosplat
|
1 mg/mL (50 mg/50 mL and 10 mg/10 mL)
|
Solution For Iv Solution
|
Antineoplastic (Cell Cycle-Nonspecific Agent)
|
Korea Unlimited Pharmaceutical, Inc.
|
Korea
|
Automatic Renewal
|
11 February 2023
|
31 March 2028
|
View |
|
DR-XY25050
|
Fluorouracil
|
Utoral
|
50 mg/mL (500 mg/10 mL and 1 g/20 mL)
|
Solution For I.V. Infusion
|
Antineoplastic
|
Korea United Pharm. Inc.
|
Korea
|
Renewal
|
09 February 2024
|
27 August 2029
|
View |
|
DR-XY25052
|
Carboplatin
|
Carbotinol
|
10 mg/mL (450 mg/45 mL)
|
Solution For Injection (I.V.)
|
Antineoplastic (Platinum Compound)
|
Korea United Pharm. Inc.
|
Korea
|
Automatic Renewal
|
30 January 2023
|
31 March 2028
|
View |
|
DR-XY25053
|
Carboplatin
|
Carbotinol
|
10 mg/mL (150 mg/15 mL)
|
Solution For Injection (I.V.)
|
Antineoplastic (Platinum Compound)
|
Korea United Pharm Inc.
|
Korea
|
Renewal
|
12 February 2024
|
02 September 2029
|
View |
|
DR-XY25056
|
Isoniazid + Pyridoxine Hydrochloride
|
Curazid Forte
|
200 mg/ 10 mg per 5 mL
|
Syrup
|
Antituberculosis
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Reconstruction)
|
22 February 2024
|
17 January 2026
|
View |
|
DR-XY25062
|
Ketoconazole
|
Latosil
|
20 mg/g
|
Cream
|
Antifungal
|
T.O. Chemicals (1979)
|
Thailand
|
Renewal
|
01 March 2024
|
14 April 2029
|
View |
|
DR-XY25078
|
Thiamine Mononitrate (Vitamin B1)+Pyridoxine Hydrochloride (Vitamin B6)+Cyanocobalamin (Vitamin B12)
|
Neuronerv
|
100 mg/5 mg/50 mcg
|
Tablet
|
Vitamin
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
03 January 2024
|
07 April 2029
|
View |
|
DR-XY2508
|
Phytomenadione
|
Konakion MM
|
10 mg/ mL
|
Solution For Injection (Iv)
|
Antihemorrhagic
|
Cenexi SAS
|
France
|
Renewal
|
31 October 2018
|
09 October 2028
|
View |
|
DR-XY25083
|
Dexamethasone Sodium Phosphate/Neomycin Sulfate/Polymyxin B Sulfate
|
Syntemax Otic Solution
|
1.0mg/3.5mg/10,000 IU%
|
Otic Solution
|
Cortecosteroid-Anti-infectives Combination
|
Ashford Pharmaceutical Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
11 April 2022
|
25 June 2027
|
View |
|
DR-XY2509
|
Propylthiouracil
|
None
|
50mg
|
Tablet
|
-
|
Surepharm Services Ltd.
|
United Kingdom
|
-
|
03 September 2020
|
13 October 2025
|
View |
|
DR-XY25098
|
Ferrous Sulfate
|
Sorbifer Durules
|
310mg
|
Sustained-Release tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
01 June 2021
|
26 September 2026
|
View |
DR-XY25101_PI_01.pdf
|
DR-XY25101
|
Dopamine hydrochloride
|
None
|
40 mg/mL (200 mg/5 mL)
|
Concentrate Solution for IV Infusion
|
Cardiac Stimulant (Adrenergic and Dopaminergic agent)
|
Siegfried Hameln GmbH
|
Germany
|
Renewal
|
22 August 2022
|
19 October 2027
|
View |
|
DR-XY25115
|
Pentoxifylline
|
Trental
|
400 mg
|
Film - Coated Tablet
|
-
|
PT. Aventis Pharma
|
Indonesia
|
-
|
26 September 2019
|
23 October 2024
|
View |
|
DR-XY25129
|
Betamethasone (as valerate)
|
Lornasone
|
1mg/g
|
Cream
|
Corticosteroid
|
T.O. Chemicals (1979)
|
Thailand
|
Renewal
|
27 March 2024
|
22 April 2029
|
View |
|
DR-XY25174
|
Levonorgestrel
|
Mirena
|
52 mg (20 mcg/24 hours)
|
Intrauterine Delivery
System
|
-
|
Bayer Oy
|
Finland
|
Initial (from Monitored Release Extension) (Variation)
|
09 August 2023
|
09 August 2028
|
View |
DR-XY25188_PI_01.pdf
|
DR-XY25188
|
Amisulpride
|
Solian
|
200 mg
|
Film-Coated Tablet
|
-
|
Delpharm Dijon
|
France
|
-
|
15 April 2021
|
03 July 2026
|
View |
|
DR-XY25192
|
Pemirolast Potassium
|
Alegysal
|
1mg/ mL (0.1%)
|
Ophthalmic Solution
|
Anti-allergy
|
Santen Pharmaceutical Co., Ltd.
|
Japan
|
Automatic Renewal
|
28 March 2022
|
30 May 2027
|
View |
|
DR-XY25225
|
BUTAMIRATE CITRATE
|
SINECOD FORTE
|
7.5 mg/5mL
|
Syrup
|
Antitussive
|
Internphil Laboratories, Inc.
|
Philippines
|
Renewal
|
09 March 2024
|
18 May 2029
|
View |
|
DR-XY25228
|
Loperamide Hydrochloride
|
Lorban
|
2 mg
|
Capsule
|
Antimotility
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
22 January 2024
|
25 May 2029
|
View |
|
DR-XY25262
|
Eicosapentaenoic acid (EPA) ethyl ester + Docosahexaenoic acid (DHA) ethyl ester
|
Omacor
|
460 mg/380 mg
|
Softgel Capsule
|
Antihyperlipidemia
|
BASF AS
|
Norway
|
Renewal
|
21 March 2019
|
28 May 2029
|